Max Healthcare Institute Ltd

Max Healthcare Institute Ltd

Max Healthcare Institute Ltd disclosed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding petitions filed before the Hon'ble National Company Law Tribunal, Cuttack Bench by the legal representatives of BRS Capital Two Pte. Limited against Kalinga Hospital Ltd, a subsidiary of the Company.

Max Healthcare Institute Ltd

Max Healthcare Institute Ltd has announced a presentation for an investor conference, which will be held on August 18, 2026, at Grand Hyatt, Mumbai. The presentation will be made available on the company's website.

Max Healthcare Institute Ltd

Max Healthcare Institute Ltd has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, with the Board of Directors approving the results at its meeting held on August 13, 2026.

Max Healthcare Institute Ltd

Max Healthcare Institute Ltd has made available the audio recording of its earnings call held on August 14, 2026, for the quarter ended June 30, 2026, on its website.

Max Healthcare Institute Ltd

Max Healthcare Institute Ltd has received an intimation from Crisil ESG Ratings & Analytics Ltd regarding the upgrade of its Environmental, Social, and Governance (ESG) ratings. The ESG rating has been upgraded to 'Strong' category from CRISIL ESG 63 to CRISIL ESG 68, and the Core ESG rating has been upgraded to CRISIL Core ESG 76 from CRISIL Core ESG 72.

Max Healthcare Institute Ltd

Max Healthcare Institute Ltd announced changes in senior management personnel, including the appointment of two new directors and the resignation of one senior director. The company also approved capital expenditure for the expansion of its Max Super Speciality Hospital, Vaishali, and in-principle approval for setting up medical colleges/institutions and amendment in the Memorandum of Association.

Max Healthcare Institute Ltd

Max Healthcare Institute Ltd reported Q1 FY27 revenue of ₹ 2,982 Cr, a 16% YoY growth, and Network Operating EBITDA of ₹ 704 Cr, a 15% YoY growth. PAT stood at ₹ 357 Cr, a 3% YoY growth. The company completed the acquisition of KHL and YPPL, and approved a capital expenditure of ₹ 425 Cr for a brownfield tower at MSSH Vaishali.

Max Healthcare Institute Ltd

Max Healthcare Institute Ltd reported Q1 FY27 revenue of ₹ 2,982 Cr, a 16% YoY growth, with Network Operating EBITDA at ₹ 704 Cr, a 15% YoY growth. Q1 PAT was ₹ 357 Cr. The company completed the acquisition of a controlling stake in Kalinga Hospital Limited and Yerawada Properties Private Limited.

Max Healthcare Institute Ltd

Max Healthcare Institute Ltd announced the outcome of its board meeting held on August 13, 2026. The board approved the unaudited standalone & consolidated financial results for the quarter ended June 30, 2026. It also approved the appointment of two senior management personnel and the resignation of another. Additionally, the board approved capital expenditure of ₹425 Crore for the expansion of Max Super Speciality Hospital, Vaishali, and gave its in-principle approval to explore setting up medical colleges/medical institutions.

Max Healthcare Institute Ltd

Max Healthcare Institute Ltd has announced its financial results for the quarter ended June 30, 2026, with the board of directors approving the unaudited standalone and consolidated financial results. The company has also made several other announcements, including the appointment of new senior management personnel, resignation of a senior director, and approval of capital expenditure for the expansion of Max Super Speciality Hospital, Vaishali.

Max Healthcare Institute Ltd

Max Healthcare Institute Ltd has allotted 3,048 equity shares to eligible employees under the Employee Stock Option Scheme 2022, increasing the paid-up equity share capital to ₹973,27,64,860.

Max Healthcare Institute Ltd

Max Healthcare Institute Ltd has granted 361,827 stock options to eligible employees under the Employee Stock Option Scheme 2022, with details provided in the annexure.

Max Healthcare Institute Ltd

Max Healthcare Institute Ltd has announced its participation in the Motilal Oswal 22nd Annual One on one & Grand Global Investor Conference on August 18, 2026. The conference will be a physical meeting at the Grand Hyatt in Mumbai. The company has assured that no unpublished price-sensitive information will be shared during the conference.

Max Healthcare Institute Ltd

Max Healthcare Institute Ltd has announced the schedule of its earnings call for Q1 FY27 results, to be held on August 14, 2026, at 11:00 AM IST.

Max Healthcare Institute Ltd

Max Healthcare Institute Ltd has scheduled a board meeting on August 13, 2026, to consider and approve unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.

Max Healthcare Institute Ltd

Max Healthcare Institute Ltd has received an order from the Hon'ble National Company Law Tribunal, Cuttack Bench, regarding a petition filed by BRS Capital Two Pte. Ltd. against Kalinga Hospital Ltd., a subsidiary of the company. The tribunal has allowed the opposite party to rectify a procedural defect and the matter has been listed for further consideration on August 19, 2026.

Max Healthcare Institute Ltd

Max Healthcare Institute Ltd held its 25th Annual General Meeting on July 30, 2026, through video conference, with 160 members present. The meeting was conducted in compliance with the Companies Act, 2013, and relevant regulations. The Company Secretary informed members that the Notice of the meeting and the Integrated Annual Report for the financial year 2025-26 were sent to all members via email or through the Company's website.

Max Healthcare Institute Ltd

Max Healthcare Institute Ltd has held its 25th Annual General Meeting (AGM) through video conference on July 30, 2026, with the requisite quorum present. The meeting was attended by the Chairman and Managing Director, Board of Directors, senior officials, and representatives of auditors. The AGM Notice and Integrated Annual Report for the financial year 2025-26 were made available to members through email, website, and physical copies.

Max Healthcare Institute Ltd

Max Healthcare Institute Ltd has announced the voting results and scrutinizer's report for its 25th Annual General Meeting, where all 8 resolutions were passed, including the adoption of audited standalone and consolidated financial statements, declaration of a final dividend of ₹2 per equity share, and re-appointment of directors.

Max Healthcare Institute Ltd

Max Healthcare Institute Ltd has announced the voting results and scrutinizer's report for its 25th Annual General Meeting, where all 8 resolutions were passed, including the adoption of audited standalone and consolidated financial statements, declaration of a final dividend of ₹2 per equity share, and re-appointment of directors.